QTREX Quantum
Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN, IINNW) has announced a broad strategic change targeted at the high-growth industries of Additively Manufactured Electronics (AME) and quantum computing connectivity. CEO Dagi Ben-Noon described the company’s shift to a multi-track wealth creation strategy in an extensive letter to shareholders. The letter included a planned corporate renaming to QTREX Quantum Ltd. to reflect the company’s new identity.
A New Strategic Framework
Three separate value tracks a targeted quantum connectivity program, a commercially active AME platform, and a medical business presently positioned as a completely owned subsidiary intended for earnings define the company’s evolution. This change is an intentional attempt to reallocate funds from legacy medical running costs to high-margin, scalable income streams in innovative electronics.
Ben-Noon noted that this move is a return to a technology that the management team is used to, having developed the AME technology while employed at Nano Dimension Ltd. The company bought Nano’s AME platform, which had over $200 million in R&D funds.
You can also read OSCAR QUBE Quantum Device Advances Space Technology
Overcoming Quantum Computing’s “Connectivity Wall”
The company’s reserve into the quantum computing infrastructure sector will be the specific point of its future expansion. The “connectivity wall” is a key hardware obstacle that quantum computers now confront. The conventional approach of using individual wires, connectors, and thermal anchors inside dilution cryostats does not scalable as qubit counts rise. Performance is limited by the extra heat, noise, and mechanical complexity introduced by these outdated technologies.
The company uses its AME platform to create a single structure that combines conductors, RF dielectrics, shielding, and thermal management instead of putting together discrete parts. High-density connectivity about 20 fully shielded conductors per square meter is made possible by this architecture, which also suppresses interaction and absorbs heat before it reaches the quantum system’s coldest stages.
Inspira and Qarakal Quantum Ltd., a project including Israel Aerospace Industries and the Hebrew University of Jerusalem, have etched a joint development agreement to validate this technology. Through this collaboration, the company hopes to transition its architecture from internal development to system-level validation in active quantum environments. This industry has enormous market potential, according to McKinsey, the quantum computing market might reach 72 billion by 2035, while Boston Consulting Group believes that the entire ecosystem could reach 170 billion by 2040.
Commercial Momentum in the AME Platform
The AME platform is already producing immediate financial results, but the quantum strategy offers long-term benefits. Inspira reported producing over $1 million in transactions within weeks of the gain, much of which had already been paid in cash.
The company is now integrating the technology with one of the “Magnificent Seven” U.S. technology companies and has successfully implemented a commercial AME system at a Tier-1 U.S. defense customer. Aerospace, missile, and defense companies use the AME platform because it can make complicated 3D geometries and high-density electronic structures. In mission-critical situations, size, weight, signal integrity, and ruggedness are crucial.
You can also read Google launches REPLIQA to advance quantum biology research
Moving the Medical Portfolio
Inspira still makes use of its medical resources even if the move toward quantum technology. The company is actively working to sell or grow parts of its medical business to provide innocuous capital for its new ventures. By the conclusion of the third quarter of 2026, management hopes to obtain a final term sheet or strategic framework for a deal.
The FDA-approved INSPIRA ART100, which is regularly used in clinical settings at respected academic medical facilities in the United States, is the core of the medical portfolio, which is still quite strong. Over 40 patients have received help from the ART100 during Pulmonary bypass procedures to date. The HYLA platform will be submitted for FDA certification in the coming months after successful validation of its high-accuracy separate configuration.
Recent global health issues like the Andes virus and Hantavirus Pulmonary Syndrome have highlighted the strategic importance of these oxygenation technologies. Noting that early external body support can result in an 80% surviving rate in decline HPS patients, Inspira has informed U.S. public health authorities of their manufacturing readiness to support critical care infrastructure.
Future Outlook
As part of its efforts to clean up its capital structure, Inspira terminated its SEPA and ATM operations in March 2026. The company is putting capital efficiency and long-term shareholder returns first by lowering the burn rate of the legacy medical business and concentrating on cash collection from AME sales.
According to CEO Dagi Ben-Noon, is a “inflection point” where the huge strategic potential of the quantum market and the near-term commercial visibility from AME converge. The company is still committed to turning its strategic alliances and intellectual property into comparable financial outcomes as it moves toward its new name, QTREX Quantum Ltd.
You can also read NYU and IBM launch Quantum Computing Postdoctoral Program
